InsideArbitrage Event Driven Monitor – March 12, 2024

Merger Arbitrage

1. ETRN: The acquistion of Equitrans Midstream (ETRN) by EQT (EQT) for a closing value of $9.1 billion in an all stock transaction. Under the terms of the merger agreement, each outstanding share of Equitrans common stock will be exchanged for 0.3504 shares of EQT common stock.
2. SCX:  The acquisition of L.S. Starrett Company (SCX) by MiddleGround Capital for $132.46 million or $16.19 per share in cash.
3. HARP:  The acquisition of Harpoon Therapeutics (HARP) by Merck & Co. (MRK) was completed on March 11, 2024. It took 63 days for this deal to be completed.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.